Evidence map›Paper›PMID 34581201›Full record

ArticleJournal of the American Heart Association2021

QT Interval Dynamics and Cardiovascular Outcomes: A Cohort Study in an Integrated Health Care Delivery System.

Neha Mantri, Meng Lu, Jonathan G Zaroff, Neil Risch, Thomas Hoffmann, Akinyemi Oni-Orisan, Catherine Lee, Eric Jorgenson, Carlos Iribarren

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Surveillance of Corrected QT Interval-Prolonging Medications upon Admission throughout Hospitalization in a Tertiary Care Geriatric Ward.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Neha MantriDepartment of Cardiology Kaiser Permanente San Francisco Medical Center San Francisco CA.
Meng LuDivision of Research Kaiser Permanente Oakland CA.
Jonathan G ZaroffDepartment of Cardiology Kaiser Permanente San Francisco Medical Center San Francisco CA.
Neil RischInstitute for Human Genetics University of California, San Francisco CA.ORCID 0000-0002-4126-2061
Thomas HoffmannInstitute for Human Genetics University of California, San Francisco CA.
Akinyemi Oni-OrisanInstitute for Human Genetics University of California, San Francisco CA.
Catherine LeeDivision of Research Kaiser Permanente Oakland CA.
Eric JorgensonDivision of Research Kaiser Permanente Oakland CA.ORCID 0000-0002-5829-8191
Carlos IribarrenDivision of Research Kaiser Permanente Oakland CA.ORCID 0000-0001-5622-1839
Kaiser Permanente · USUniversity of California, San Francisco · USKaiser Permanente San Francisco Medical Center · US

Funding

Population-based pharmacogenomic assessment of QT prolongationR01HL140924 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI IRIBARREN, CARLOS · 2018 to 2021
$3.0M
NHLBI NIH HHS R01 HL140924
6 · The paper itself

Abstract

Background Long QT has been associated with ventricular dysrhythmias, cardiovascular disease (CVD) mortality, and sudden cardiac death. However, no studies to date have investigated the dynamics of within-person QT change over time in relation to risk of incident CVD and all-cause mortality in a real-world setting. Methods and Results A cohort study among members of an integrated health care delivery system in Northern California including 61 455 people (mean age, 62 years; 60% women, 42% non-White) with 3 or more ECGs (baseline in 2005-2009; mean±SD follow-up time, 7.6±2.6 years). In fully adjusted models, tertile 3 versus tertile 1 of average QT corrected (using the Fridericia correction) was associated with cardiac arrest (hazard ratio [HR], 1.66), heart failure (HR, 1.62), ventricular dysrhythmias (HR, 1.56), all CVD (HR, 1.31), ischemic heart disease (HR, 1.28), total stroke (HR, 1.18), and all-cause mortality (HR, 1.24). Tertile 3 versus tertile 2 of the QT corrected linear slope was associated with cardiac arrest (HR, 1.22), ventricular dysrhythmias (HR, 1.12), and all-cause mortality (HR, 1.09). Tertile 3 versus tertile 1 of the QT corrected root mean squared error was associated with ventricular dysrhythmias (HR, 1.34), heart failure (HR, 1.28), all-cause mortality (HR, 1.20), all CVD (HR, 1.14), total stroke (HR, 1.08), and ischemic heart disease (HR, 1.07). Conclusions Our results demonstrate improved predictive ability for CVD outcomes using longitudinal information from serial ECGs. Long-term average QT corrected was more strongly associated with CVD outcomes than the linear slope or the root mean squared error. This new evidence is clinically relevant because ECGs are frequently used, noninvasive, and inexpensive.

Indexed as

Heart FailureLong QT SyndromeMyocardial IschemiaArrhythmias, CardiacCohort StudiesDeath, Sudden, CardiacDelivery of Health CareFemaleHumansMaleMiddle Agedepidemiologylong QTQT intervalshort QT syndrome

Identifiers

PMID34581201
PMCPMC8649135
OpenAlexW3202565566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.